
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
HNF-6 CRISPR/Cas9 KO Plasmid (m) | sc-420893 | 20 µg | $397.00 |
Onecut1 encodes the homeobox transcription factor HNF-6, a key regulator of endoderm-derived tissue differentiation in mouse, including pancreatic, hepatic, and biliary lineages. HNF-6 binds cis-regulatory elements to coordinate transcriptional programs controlling epithelial morphogenesis, ductal development, and cell fate decisions, and it functionally intersects with Notch, Wnt/β-catenin, and TGF-β signaling during organogenesis and tissue homeostasis. Altered Onecut1 activity has been linked to defects in pancreatic endocrine development and ductal patterning, making it relevant to studies of metabolic dysfunction and developmental phenotypes. In experimental systems, Onecut1/HNF-6 perturbation is used to dissect transcriptional networks that couple chromatin state to lineage specification and organ maturation.
HNF-6 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Onecut1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Onecut1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Onecut1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish HNF-6 protein expression.
This CRISPR knockout system enables efficient generation of Onecut1-deficient cell models for investigation of HNF-6 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.